Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers

• PaxMedica, Inc. PXMD shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
• Senti Biosciences, Inc. SNTI gained 83% to $0.5298 after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties.
• Tharimmune, Inc. THAR shares climbed 57.8% to $0.2488 as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
• TransMedics Group, Inc. TMDX shares gained 56.7% to $63.03 after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.
• Singular Genomics Systems, Inc. OMIC rose 39.1% to $0.5350.
• Olaplex Holdings, Inc. OLPX gained 39% to $1.92 following strong quarterly results.
• Datadog, Inc. DDOG climbed 28.6% to $102.28 after the company reported better-than-expected third-quarter results and issued strong guidance.
• Augmedix, Inc. AUGX shares rose 24% to $5.64 following strong third-quarter results.
• Rover Group, Inc. ROVR gained 23.7% to $7.99 following upbeat results. The company’s board also approved extension of share repurchase program with additional $100 million.
• MacroGenics, Inc. MGNX rose 20.6% to $6.57 after posting a profit for the third quarter.
• Jowell Global Ltd. JWEL climbed 18% to $1.96.
• Triumph Group, Inc. TGI rose 17.6% to $9.30 following strong quarterly results.
• Alteryx, Inc. AYX shares jumped 17.3% to $35.74 after the company reported better-than-expected third-quarter financial results.
• Unisys Corporation UIS shares jumped 16.7% to $3.3780 after the company posted upbeat third-quarter results and raised FY23 revenue growth forecast.
• Thoughtworks Holding, Inc. TWKS rose 16.2% to $4.2050 after the company posted upbeat third-quarter results.
• TaskUs, Inc. TASK gained 16% to $11.90 after the company reported better-than-expected third-quarter financial results and issued FY23 revenue guidance above estimates.
• Myriad Genetics, Inc. MYGN rose 15.8% to $18.92 after the company posted upbeat third-quarter results.
• Planet Fitness, Inc. PLNT climbed 15.8% to $63.92 after the company reported better-than-expected third-quarter financial results and raised FY23 revenue growth guidance.
• EverQuote, Inc. EVER gained 15.8% to $8.62 following strong sales.
• Oscar Health, Inc. OSCR climbed 14.3% to $6.53 following strong results.
• Hims & Hers Health, Inc. HIMS rose 13.9% to $7.16 after the company reported better-than-expected third-quarter sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
• Surgery Partners, Inc. SGRY rose 13.2% to $28.08 following upbeat results.
• Vimeo, Inc. VMEO gained 13.2% to $3.7950 following upbeat results.
• MongoDB, Inc. MDB climbed 12.7% to $374.62.
• PRA Group, Inc. PRAA climbed 11.3% to $16.12 following better-than-expected results.
• Snowflake Inc. SNOW rose 10.9% to $159.93 in sympathy with Datadog, which reported better-than-expected Q3 results and issued strong guidance.
• DocGo Inc. DCGO gained 10.2% to $6.39 following strong sales.
• Wearable Devices Ltd. WLDS surged 9.7% to $0.8006.
• GSE Systems, Inc. GVP rose 9.6% to $3.5961. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.
• FibroGen, Inc. FGEN gained 8.4% to $0.6062 following upbeat results.
• Tripadvisor, Inc. TRIP shares rose 4.8% to $16.89 after the company reported better-than-expected third-quarter financial results.

Losers

• Ventyx Biosciences, Inc. VTYX shares fell 80.8% to $2.71 after the company announced efficacy results from the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target to support further development of VTX958 in psoriasis.
• Alto Ingredients, Inc. ALTO fell 58.1% to $2.0594 after the company reported mixed third-quarter financial results.
• Worldwide Webb Acquisition Corp. WWAC fell 51% to $3.56.
• Oportun Financial Corporation OPRT fell 47% to $3.08 after reporting a loss for the third quarter.
• Royalty Management Holding Corporation RMCO dipped 41.6% to $5.80.
• Aura Biosciences, Inc. AURA fell 33% to $7.37. Aura Biosciences priced its public offering of 11 million common shares at $9 per share.
• ThredUp Inc. TDUP fell 30.5% to $2.3901 following weak results.
• ADTRAN Holdings, Inc. ADTN shares fell 28% to $5.28 following a wider-than-expected quarterly loss.
• Olo Inc. OLO fell 27% to $4.2650 following third-quarter results.
• Ameresco, Inc. AMRC shares declined 27% to $19.42 following downbeat third-quarter results.
• Air Transport Services Group, Inc. ATSG dropped 24.4% to $15.29. Air Transport Services reported weaker-than-expected results for its third quarter. The company also named Joe Hete, current Chairman of the Board and its former longtime CEO, as its CEO, effective immediately.
• MSP Recovery, Inc. LIFW shares fell 24.2% to $7.32 after jumping 252% on Monday.
• Coherus BioSciences, Inc. CHRS shares fell 23.2% to $2.72 after the company reported mixed third-quarter financial results.
• Clover Health Investments, Corp. CLOV shares fell 20.1% to $0.8966 following weak quarterly sales.
• Nine Energy Service, Inc. NINE fell 19.4% to $2.7631 following downbeat sales.
• Tactile Systems Technology, Inc. TCMD fell 17.2% to $10.46 following quarterly results.
• Sterling Infrastructure, Inc. STRL declined 16.3% to $62.42 following weak sales.
• ICU Medical, Inc. ICUI fell 16.3% to $85.34 following downbeat sales.
• EverCommerce Inc. EVCM dipped 15% to $8.16 following weak sales.
• Sanmina Corporation SANM shares fell 14.5% to $45.15 after the company reported worse-than-expected fourth-quarter financial results.
• Alpine Immune Sciences, Inc. ALPN fell 11.4% to $12.49. Alpine Immune Sciences priced its $150 million public offering of 8.8 million common shares at $12.50 per share.
• CNH Industrial N.V. CNHI fell 8.6% to $10.36 after the company reported mixed third-quarter financial results and issued guidance.
• Sage Therapeutics, Inc. SAGE declined 7.4% to $19.09 following third-quarter results.

Now Read This: Ethereum Falls Below This Key Level; Neo Becomes Top Loser